Glenmark launches generic anticoagulant injectable emulsion

Glenmark Pharmaceuticals has launched Phytonadione injectable emulsion through its US arm, targeting anticoagulant markets. The 10 mg/mL single-dose ampules are bioequivalent to Vitamin K1 Injectable Emulsion USP. This launch diversifies Glenmark's institutional product portfolio and reinforces their commitment to offering affordable alternatives, with the market valued at approximately USD 19.7 million annually.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ODfk86F
via IFTTT